B4F2T5 AF NFT

Isoleucine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeic62gkukzemxggxlhpstttbuhiryonzqcqzwqphnyfoaj62vp7g5q/metadata.json
IPFS of structure file: 
bafybeicby2ntpizvcv5nfsrr2gfwuaq7yk2ycra2d4chpswobyrquxu7eu/AF-B4F2T5-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x7a1388B6Aad67B04634A32f63b8A6D6005eab86c
First NFT owner address (bech32): 
genesis10gfc3d426easgc62xtmrhzndvqz74wrv0qh3l8
Current NFT ID #449065 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
449065
Accession (UniProt):
B4F2T5
Name::
Isoleucine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
PROTEUS MIRABILIS (STRAIN HI4320)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B4F2T5 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B4F2T5|SYI_PROMH Isoleucine--tRNA ligase OS=Proteus mirabilis (strain HI4320) OX=529507 GN=ileS PE=3 SV=1 MSDYKNTLNLPETGFPMRGDLAKREPEMLSRWYKEGLYQAIRQAKSGKKTFILHDGPPYANGNIHIGHSVNKILKDIIIKSKGLSGFDSPYIPGWDCHGLPIELKVEQIVGKPGEKVSAAQFREECRKYAYEQIEAQKKDFIRLGVLGDWDKPYLTMDYKTEANTIRALARIIANGHLLKGAKPVHWCTACGSSLAEAEVEYYDKTSPSIDVRFRAVDSNAVAAKFGVVTDKPISLVIWTTTPWTLPANRAIALNGEFNYALVSFDDECVILAADLVEHVMKRIGVTDWAVLGECKGSDLELLRFNHPFMGFDVPAILGDHVTLDAGTGAVHTAPGHGPDDFVIGQKYGLEVANPVGPNGCYLPNTYPTLDGVFVFKANDVIVELLKEKGALLHHEAMQHSYPCCWRHKTPVIFRATPQWFIGMDKNGLRQQSLKEIKGVKWIPDWGQARIESMVENRPDWCISRQRTWGTPMSLFVHKETQEPHPRTLELMEEVAKRVEVSGIQAWWDLDIRELLGDEADDYMKTPDTLDVWFDSGSTHSTVVDARPEFHGNSADLYLEGSDQHRGWFMSSLMISTAIKGKAPYREVLTHGFTVDGQGRKMSKSIGNTVSPQDVMNKLGADILRLWVASTDYTGEIAVSDEILKRSADTYRRIRNTARFFLANLNGFDPAKHQVKPEEMVILDRWAVGRAKAAQEDILKHYENYDFHNVIQRLMQFCSVEMGSFYLDIIKDRQYTAKSDSVARRSCQTALYHIIEALVRWMAPIMSFTADEIWAQLPGERAKFVFTQEWYTDLFGLEASETLNDEYWAELLAVRSEVNKVLEQARTDKQLRGSLEAAVTLYADKALAEKLNALGNELRFVLLTSQATVADIHDAPENALASDMAGLKIVLSKAQGEKCPRCWHYATDIGQVAEHADLCGRCVTNVAGNGEERKFA